Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hangxiang Wang

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Trends in Immunology|July 12, 2025
Repurposing of old drugs for unleashing innate immunityFanchao Meng, Hangxiang Wang
Chembiochem : a European Journal of Chemical Biology|August 21, 2009
Recent progress in strategies for the creation of protein-based fluorescent biosensorsHangxiang Wang, Eiji Nakata, Itaru Hamachi
The Journal of Organic Chemistry|August 22, 2014
N-heterocyclic carbene-stabilized palladium complexes as organometallic catalysts for bioorthogonal cross-coupling reactionsXueji Ma, Hangxiang Wang, Wanzhi Chen
Organic Letters|August 22, 2014
Rhodium-catalyzed transannulation of N-sulfonyl-1,2,3-triazoles and epoxides: regioselective synthesis of substituted 3,4-dihydro-2H-1,4-oxazinesXueji Ma, Shanfei Pan, Hangxiang Wang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 1, 2006
Pyrene-stacked nanostructures constructed in the recombinant tobacco mosaic virus rod scaffoldMasayuki Endo, Hangxiang Wang, Mamoru Fujitsuka, et al.
International Journal of Pharmaceutics|September 16, 2021
Microfluidic assembly of small-molecule prodrug cocktail nanoparticles with high reproducibility for synergistic combination of cancer therapyTingting Li, Jiangling Huang, Min Wang, et al.
Chembiochem : a European Journal of Chemical Biology|July 9, 2024
STING-Activating Small Molecular Therapeutics for Cancer ImmunotherapyChuhan Huang, Tianrui Tong, Lulu Ren, et al.
Nanoscale|May 31, 2023
Transforming a highly toxic agent DM1 into injectable safe nanomedicines <i>via</i> prodrug self-assembly for the treatment of taxane-resistant cancerJiangling Huang, Shanshan Song, Min Wang, et al.
Cancer Letters|February 7, 2018
The Hippo pathway as a drug target in gastric cancerYiting Qiao, Tongyu Li, Shusen Zheng, et al.
Chemical Communications (Cambridge, England)|August 1, 2018
Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatinTao Fang, Zhijian Ye, Jiaping Wu, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Trends in Immunology|July 12, 2025
Repurposing of old drugs for unleashing innate immunityFanchao Meng, Hangxiang Wang
Chembiochem : a European Journal of Chemical Biology|August 21, 2009
Recent progress in strategies for the creation of protein-based fluorescent biosensorsHangxiang Wang, Eiji Nakata, Itaru Hamachi
The Journal of Organic Chemistry|August 22, 2014
N-heterocyclic carbene-stabilized palladium complexes as organometallic catalysts for bioorthogonal cross-coupling reactionsXueji Ma, Hangxiang Wang, Wanzhi Chen
Organic Letters|August 22, 2014
Rhodium-catalyzed transannulation of N-sulfonyl-1,2,3-triazoles and epoxides: regioselective synthesis of substituted 3,4-dihydro-2H-1,4-oxazinesXueji Ma, Shanfei Pan, Hangxiang Wang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 1, 2006
Pyrene-stacked nanostructures constructed in the recombinant tobacco mosaic virus rod scaffoldMasayuki Endo, Hangxiang Wang, Mamoru Fujitsuka, et al.
International Journal of Pharmaceutics|September 16, 2021
Microfluidic assembly of small-molecule prodrug cocktail nanoparticles with high reproducibility for synergistic combination of cancer therapyTingting Li, Jiangling Huang, Min Wang, et al.
Chembiochem : a European Journal of Chemical Biology|July 9, 2024
STING-Activating Small Molecular Therapeutics for Cancer ImmunotherapyChuhan Huang, Tianrui Tong, Lulu Ren, et al.
Nanoscale|May 31, 2023
Transforming a highly toxic agent DM1 into injectable safe nanomedicines <i>via</i> prodrug self-assembly for the treatment of taxane-resistant cancerJiangling Huang, Shanshan Song, Min Wang, et al.
Cancer Letters|February 7, 2018
The Hippo pathway as a drug target in gastric cancerYiting Qiao, Tongyu Li, Shusen Zheng, et al.
Chemical Communications (Cambridge, England)|August 1, 2018
Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatinTao Fang, Zhijian Ye, Jiaping Wu, et al.
Pageof 11